Agenda

Return

C. 95

To:	Board of Supervisors
From:	Anna Roth, Health Services Director
Date:	January 5, 2021

Contra

Costa

County

Subject:

Purchase Order with Sanofi Pasteur, Inc.

APPROVE	OTHER
RECOMMENDATION OF CNTY ADMINISTRATOR	RECOMMENDATION OF BOARD COMMITTEE

Action of Board On: 01/05/2021

APPROVED AS RECOMMENDED

OTHER

Clerks Notes:

VOTE OF SUPERVISORS

AYE:

John Gioia, District I Supervisor
Candace Andersen, District II Supervisor
Diane Burgis, District III Supervisor
Karen Mitchoff, District IV Supervisor
Federal D. Glover, District V Supervisor

Contact:	Jaspreet Benepal, 925-370-5101
cc:	Irene Segovia Marcy Wilhelm

I hereby certify that this is a true and correct copy of an action taken and entered on the minutes of the Board of Supervisors on the date shown.
ATTESTED: January 5, 2021
Monica Nino, County Administrator

BY:	, Deputy

RECOMMENDATION(S):

APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, a purchase order with Sanofi Pasteur, Inc., in an amount not to exceed $375,000 for the purchase of vaccines and injectable medications at the Contra Costa Regional Medical Center (CCRMC) and Health Centers, for the period from January 1, 2021 through December 31, 2021.

FISCAL IMPACT:

This purchase order will result in an annual expenditure of up to $375,00 and will be 100% funded by Hospital Enterprise Fund I revenues.

BACKGROUND:

Sanofi Pasteur, Inc. furnishes pharmaceuticals for patient care provided in the hospital and the clinics. Immune globulin intravenous (IGIV) is a sterilized solution made from human plasma. It contains the antibodies to help the body protect itself against infection from various diseases. IGIV is used to treat primary immunodeficiency, and to reduce the risk of infection in individuals with poorly functioning immune systems. IGIV is also used to increase platelets (blood clotting cells) in people with idiopathic thrombocytopenic purpura (ITP) and to prevent aneurysm caused by a weakening of the main artery in the heart associated with Kawasaki syndrome and many, many critical illnesses.

These vaccines and other injectable medications are essential in patient care and we have been purchasing vaccines and other injectable medications from Sanofi Pasteur since 2007. The majority of our vaccines are purchased from Sanofi. Sanofi is the maker of critical injectables for the hospital settings anywhere from different types of Insulins for Type I and Type II diabetic patient population to vaccines to different immune globulin formulations. None of the above formulations can be replaced by any other compounds. Long acting insulin glargine is number one insulin used at CCRMC in our diabetic population admitted to the hospital and lives would be at risk should this medication not be available. At CCRMC these patients present to the hospital setting as well as the infusion clinic to receive the IVIG. These are life-saving medications for patients in need.

CONSEQUENCE OF NEGATIVE ACTION:

If this purchase order is not approved, the County will not be able to provide needed vaccines and other pharmaceutical products to its patient population at CCRMC and Health Centers.